KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Staar Surgical (STAA) Invested Capital (2016 - 2025)

Historic Invested Capital for Staar Surgical (STAA) over the last 16 years, with Q3 2025 value amounting to $353.8 million.

  • Staar Surgical's Invested Capital fell 1736.47% to $353.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $353.8 million, marking a year-over-year decrease of 1736.47%. This contributed to the annual value of $397.3 million for FY2024, which is 294.88% up from last year.
  • As of Q3 2025, Staar Surgical's Invested Capital stood at $353.8 million, which was down 1736.47% from $336.6 million recorded in Q2 2025.
  • Staar Surgical's 5-year Invested Capital high stood at $428.1 million for Q3 2024, and its period low was $198.6 million during Q1 2021.
  • Moreover, its 5-year median value for Invested Capital was $337.7 million (2023), whereas its average is $325.8 million.
  • In the last 5 years, Staar Surgical's Invested Capital skyrocketed by 3403.6% in 2021 and then plummeted by 1772.9% in 2025.
  • Staar Surgical's Invested Capital (Quarter) stood at $258.6 million in 2021, then increased by 29.99% to $336.1 million in 2022, then rose by 14.83% to $386.0 million in 2023, then rose by 2.95% to $397.3 million in 2024, then fell by 10.96% to $353.8 million in 2025.
  • Its Invested Capital was $353.8 million in Q3 2025, compared to $336.6 million in Q2 2025 and $350.0 million in Q1 2025.